Analysis on individual difference in pharmacokinetics of edoxaban and its metabolites, and investigation on predictive parameters of edoxaban response and adverse effects in Japanese patiens
Latest Information Update: 08 Jul 2022
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation
- Focus Pharmacokinetics
- 06 Jul 2022 Planned End Date changed from 31 Aug 2022 to 31 Aug 2023.
- 03 Sep 2020 New trial record